Congenital Hole in the Heart Wall in Dogs (Ventricular Septal Defect, VSD)
- Synonyms: Ventricular Septal Defect
- Occurrence: very rare
- Location of disease: Chest
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
A ventricular septal defect (VSD) in dogs is a congenital heart problem in which there is a hole in the wall between the two heart chambers, the ventricles. This malformation leads to abnormal blood flow between the ventricles, which can impair heart function.
The most important facts at a glance
A ventricular septal defect (VSD) is a congenital heart defect in dogs where the separation of the heart chambers is incomplete. This condition occurs more frequently in certain dog breeds and can have genetic, environmental, and possibly dietary causes. The size of the defect varies and influences the severity of symptoms. While small defects often cause no problems, larger defects can lead to heart failure as the heart is excessively strained. Common symptoms include Respiratory distress, reduced exercise tolerance, and increased heart and respiratory rates. Diagnosis is made through clinical examination and imaging, such as echocardiograms, to visualize and assess the defect. Treatment depends on the size of the defect and the symptoms. Small defects usually only require monitoring, while larger symptomatic defects can be treated medically or surgically. Surgical interventions are complex and are performed in specialized centers. The prognosis varies; dogs with small defects can lead a normal life, while with larger defects, a reduced life expectancy is possible. Preventive measures include responsible breeding practices and regular veterinary examinations. Research focuses on genetic analyses and improving diagnostic and therapeutic methods to improve the quality of life for dogs with VSD.
Causes
The wall that separates the two ventricles is called the ventricular septum. This septum usually develops during embryonic development and ensures that oxygen-rich blood is pumped from the left ventricle into the body, while oxygen-poor blood from the right ventricle goes to the lungs. A ventricular septal defect occurs when this wall does not close completely.
VSD is one of the most common congenital heart diseases in dogs and occurs more frequently in certain breeds. It is a multifactorial disease that can have genetic, environmental, and possibly dietary causes. While the exact genetic mechanisms are not yet fully understood, inheritance is thought to play a role, especially in breeds that are prone to heart defects.
The size of the defect can vary, which affects the type and severity of symptoms. Small defects may cause no noticeable problems, while larger defects can lead to severe impairment of heart function. A significant defect can cause the heart to work harder, leading to cardiac muscle hypertrophy and, ultimately, heart failure.
Symptoms
The symptoms of a ventricular septal defect in dogs depend on the size of the defect and the resulting impairment of heart function. With small defects, dogs may remain asymptomatic and live a normal life. With larger defects, however, noticeable symptoms can occur.
The most common symptoms include Respiratory distress, Cough, rapid or labored breathing (dyspnea), and reduced exercise tolerance. Dogs with a VSD may also show reduced growth because the body does not receive enough oxygen to support growth.
Other signs may include Lethargy, weakness, fainting episodes, and a bluish discoloration of the tongue or mucous membranes (cyanosis). These symptoms result from the body not receiving enough oxygen from the heart.
Therapy
The treatment of a VSD depends on the size of the defect and the severity of the symptoms. For small defects that do not cause symptoms, regular monitoring may be sufficient to monitor the progression of the disease.
In symptomatic dogs, drug therapy may be used to support heart function and relieve symptoms. Medications such as diuretics, ACE inhibitor, and cardiac glycosides can help reduce cardiac workload and control fluid buildup.
In more severe cases, surgery may be required to close the defect. However, this operation is complex and is typically only performed in specialized centers. The decision to operate depends on many factors, including the dog’s general health and the risk of the procedure.
Prognosis and follow-up care
The prognosis for dogs with a VSD varies depending on the size of the defect and the treatment options. Dogs with small defects and no symptoms can live a normal life and have a normal life expectancy. However, regular veterinary check-ups are important to detect possible changes early.
Dogs with larger defects that cause symptoms have a more guarded prognosis. With appropriate medical treatment, many of these dogs can achieve a good quality of life, even if they may have a reduced life expectancy.
Dogs undergoing surgery may experience a significant improvement in their symptoms, yet the success of the surgery depends on various factors, including the surgeon’s experience and the dog’s individual response to the procedure.
Prevention
Since VSD is a congenital condition, there are no specific prevention measures. The best prevention is to promote responsible breeding practices and to screen potentially affected breeds for heart defects before they are used for breeding.
Genetic counseling programs can help reduce the risk of passing on heart defects in certain breeds. Breeders should work together to increase genetic diversity and reduce the frequency of heart defects in the population.
Regular veterinary examinations and early diagnosis are crucial to monitor the health of dogs with VSD and, if necessary, initiate timely treatment. A balanced diet and appropriate physical activity can also contribute to promoting the general health and well-being of dogs.
Outlook on current research
Research into ventricular septal defects (VSD) in dogs has made significant progress in recent years. Researchers are currently focusing on the genetic basis of these heart defects, as certain dog breeds show a higher predisposition to VSD. Genetic analyses could help identify specific genes associated with the development of VSD. By understanding these genetic factors, scientists hope to develop preventive measures and targeted breeding strategies in the future to reduce the incidence of VSD.
Another research focus is on the development and improvement of diagnostic techniques. Modern imaging technologies such as three-dimensional echocardiography allow for more detailed insights into the structure and function of the heart in affected dogs. These advanced diagnosis methods can help detect the disease earlier and better assess the severity of the defect. This allows veterinarians to create tailored treatment plans that are adapted to the individual needs of the dog.
In therapeutic research, intensive work is being done on new surgical and medicinal treatment approaches. Innovative surgical techniques, such as minimally invasive procedures, are being developed to reduce risks and recovery times after surgery. In addition, new medications are being tested that aim to alleviate the symptoms of VSD and improve the quality of life of affected dogs. These treatment strategies could be particularly important for dogs with more severe forms of VSD.
Interdisciplinary collaboration between veterinarians, geneticists, and cardiologists plays a crucial role in VSD research. Through the exchange of knowledge and resources, more comprehensive studies can be conducted, contributing to a deeper understanding of the disease. Collaboration with international research groups is also encouraged to collect global data and standardize research results.
A forward-looking research area is regenerative medicine. Scientists are investigating the potential of stem cells and tissue engineering to repair or replace damaged heart tissue. Although this research is still in its early stages, regenerative therapies could offer a groundbreaking possibility for the treatment of VSD in the future.
In summary, research into ventricular septal defects in dogs is a dynamic and rapidly developing field. Advances in genetics, diagnosis, and therapy offer hope for better prevention strategies and treatment options for affected dogs. Continuous research and technological progress aim to significantly improve the quality of life and life expectancy of dogs with VSD.
Frequently Asked Questions (FAQs)
1. What is a ventricular septal defect (VSD) in dogs?
2. What symptoms does a dog with VSD show?
3. How is a VSD diagnosed in dogs?
4. What treatment options are available for dogs with VSD?
5. Can dogs with VSD lead a normal life?
6. Is VSD in dogs hereditary?
7. Which dog breeds are particularly susceptible to VSD?
8. What are the long-term complications of an untreated VSD?
9. How often should a dog with VSD be vet-checked?
10. Are there preventive measures against VSD in dogs?
Literature
- Graczyk, S., Grzeczka, A., & Pasławska, U. (2025). A comprehensive review of canine and feline ventricular septal defects—From pathogenesis to long-term follow-up. Animals, 15(6), Article 850. https://doi.org/10.3390/ani15060850
- Bomassi, E., Misbach, C., Tissier, R., Gouni, V., Trehiou-Sechi, E., Petit, A. M., Desmyter, A., Damoiseaux, C., Pouchelon, J.-L., & Chetboul, V. (2015). Signalment, clinical features, echocardiographic findings, and outcome of dogs and cats with ventricular septal defects: 109 cases (1992–2013). Journal of the American Veterinary Medical Association, 247(2), 166–175. https://doi.org/10.2460/javma.247.2.166
- Thomas, W. P. (2005). Echocardiographic diagnosis of congenital membranous ventricular septal aneurysm in the dog and cat. Journal of the American Animal Hospital Association, 41, 215–220. https://doi.org/10.5326/0410215
- Fujii, Y., Fukuda, H., Machida, N., & Wakao, Y. (2004). Transcatheter closure of congenital ventricular septal defects in 3 dogs with a detachable coil. Journal of Veterinary Internal Medicine, 18(6), 911–914. https://doi.org/10.1111/j.1939-1676.2004.tb02643.x
- van de Watering, A. G., & Szatmári, V. (2022). Spontaneous closure of an isolated congenital perimembranous ventricular septal defect in two dogs. BMC Veterinary Research, 18, Article 162. https://doi.org/10.1186/s12917-022-03266-9
- Rausch, W. P., & Keene, B. W. (2003). Spontaneous resolution of an isolated ventricular septal defect in a dog. Journal of the American Veterinary Medical Association, 223(2), 219–220, 197. https://doi.org/10.2460/javma.2003.223.219